MicroRNA 4509-3 (MIR4509-3)

MicroRNA 4509-3 is a human microRNA (miRNA), a short non-coding RNA approximately 20–24 nucleotides in length, presumed to participate in post-transcriptional regulation of gene expression like other miRNAs[6]. General knowledge about microRNAs indicates their involvement in gene silencing by binding target mRNAs and directing translational repression or degradation[1][2][6]. However, no experimentally validated functional data, disease associations, or targeting drugs are currently available for MIR4509-3 specifically, making it a biochemically identified but functionally uncharacterized microRNA. There is no evidence in major gene or miRNA databases or the biomedical literature that MIR4509-3 (microRNA 4509-3) is a recognized therapeutic target, candidate biomarker, or has specific biological/pathological functions documented to date[6]. This microRNA may have been identified via deep sequencing and annotation efforts, but it lacks validation, functional characterization, or clinical research links—a common situation for a large proportion of recently annotated human miRNAs. Nomenclature is consistent with current miRNA naming conventions: "MIR" for the gene, "mir" for the human form, plus the "-3" indicating the mature product from the 3' arm of the precursor hairpin[6]. Information about MIR4509-3 is currently restricted to basic gene annotation pages with no experimental or functional data available. Its designation as a "target" is misleading; it is not a receptor, enzyme, drug target, or recognized disease gene at present. If your intent was to find therapeutically actionable targets, more established microRNAs or protein-coding genes should be prioritized.

Other names

MIR4509-3hsa-mir-4509-3hsa-mir-4509-3-3p